Hello, Sign in
My Account
My Account
New customer? Start here
| Catalog # | Availability | Size | Quantity | Unit Price | Save For Later Wish List | |
|---|---|---|---|---|---|---|
| VAG0455-50 | 7 days | 50 µg | $1,800.00 |
Select product before adding to cart
|
||
| VAG0455-150 | 7 days | 150 µg | $4,500.00 | |||
| VAG0455-250 | 7 days | 250 µg | $4,800.00 |
Product Overview | |
| Name | SARS Spike (306-527) |
|---|---|
| Description | |
| SARS Spike Receptor Binding Domain(306-527 a.a.), Recombinant | |
| Accession (Primary) | AAP13567.1 |
| Introduction | |
| Severe acute respiratory syndrome (SARS) has a new causative agent identified as Coronavirus. SARS Associated Coronavirus Spike is one of the main surface antigens of Coronavirus, making it one of the main candidates for vaccines. Diseases caused by Coronaviruses are usually controlled by CD8 T cells. | |
| Source | |
| Escherichia Coli. | |
| Physical Appearance | |
| Sterile Filtered clear solution. | |
| Formulation | |
| SARS Spike protein solution is supplied in PBS. | |
| Stability | |
| Protein is shipped on ice packs. Upon arrival, Store at -20°C. | |
| Purity | |
| Protein is >90% pure as determined SDS-PAGE. | |
| Purification Method | |
| Purified by proprietary chromatographic technique. | |
| Specificity | |
| Immunoreactive with sera of SARS-infected individuals. | |
| Precautions | |
| SARS Spike (306-527) is for research use only and not for use in diagnostic or therapeutic procedures. | |
Target Information: ( AAP13567.1 ) | |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from ADMEbio to advance their research.
Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
Thank you,
ADMEbio Team
ADMEbio welcomes feedback from our customers.
Thank you,
ADMEbio Team
